184 related articles for article (PubMed ID: 26899498)
41. Aberrant regulation and function of Src family tyrosine kinases: their potential contributions to glutamate-induced neurotoxicity.
Hossain MI; Kamaruddin MA; Cheng HC
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):684-91. PubMed ID: 21973029
[TBL] [Abstract][Full Text] [Related]
42. Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application.
Osman MM; Lulic D; Glover L; Stahl CE; Lau T; van Loveren H; Borlongan CV
Neuropeptides; 2011 Dec; 45(6):359-68. PubMed ID: 21592568
[TBL] [Abstract][Full Text] [Related]
43. Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity.
Wei X; Ma Z; Fontanilla CV; Zhao L; Xu ZC; Taggliabraci V; Johnstone BH; Dodel RC; Farlow MR; Du Y
Neuroscience; 2008 Sep; 155(4):1098-105. PubMed ID: 18657598
[TBL] [Abstract][Full Text] [Related]
44. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
[TBL] [Abstract][Full Text] [Related]
45. Neuroprotection in acute ischemic stroke--current status.
Auriel E; Bornstein NM
J Cell Mol Med; 2010 Sep; 14(9):2200-2. PubMed ID: 20716132
[TBL] [Abstract][Full Text] [Related]
46. PSD-95: An Effective Target for Stroke Therapy Using Neuroprotective Peptides.
Ugalde-Triviño L; Díaz-Guerra M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830481
[TBL] [Abstract][Full Text] [Related]
47. A Neurotoxic
Granzotto A; Canzoniero LMT; Sensi SL
Front Mol Neurosci; 2020; 13():600089. PubMed ID: 33324162
[TBL] [Abstract][Full Text] [Related]
48. Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase.
Li W; Xue J; Niu C; Fu H; Lam CS; Luo J; Chan HH; Xue H; Kan KK; Lee NT; Li C; Pang Y; Li M; Tsim KW; Jiang H; Chen K; Li X; Han Y
Mol Pharmacol; 2007 May; 71(5):1258-67. PubMed ID: 17299028
[TBL] [Abstract][Full Text] [Related]
49. The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage.
Jantas D; Gręda A; Gołda S; Korostyński M; Lasoń W
Neuropharmacology; 2016 Dec; 111():195-211. PubMed ID: 27600687
[TBL] [Abstract][Full Text] [Related]
50. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.
Seki M; Lipton SA
Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130
[TBL] [Abstract][Full Text] [Related]
51. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity.
Chen CM; Lin JK; Liu SH; Lin-Shiau SY
J Neurosci Res; 2008 Sep; 86(12):2696-704. PubMed ID: 18478543
[TBL] [Abstract][Full Text] [Related]
52. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.
Vercelli A; Biggi S; Sclip A; Repetto IE; Cimini S; Falleroni F; Tomasi S; Monti R; Tonna N; Morelli F; Grande V; Stravalaci M; Biasini E; Marin O; Bianco F; di Marino D; Borsello T
Cell Death Dis; 2015 Aug; 6(8):e1854. PubMed ID: 26270349
[TBL] [Abstract][Full Text] [Related]
53. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Doraiswamy PM
CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
[TBL] [Abstract][Full Text] [Related]
54. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke.
Yuan J
Apoptosis; 2009 Apr; 14(4):469-77. PubMed ID: 19137430
[TBL] [Abstract][Full Text] [Related]
55. AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures.
Meade AJ; Meloni BP; Cross J; Bakker AJ; Fear MW; Mastaglia FL; Watt PM; Knuckey NW
J Neurochem; 2010 Jan; 112(1):258-70. PubMed ID: 19878434
[TBL] [Abstract][Full Text] [Related]
56. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
Xia Y; Xing JZ; Krukoff TL
Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
[TBL] [Abstract][Full Text] [Related]
57. Neuroprotective potential of ceftriaxone in in vitro models of stroke.
Lipski J; Wan CK; Bai JZ; Pi R; Li D; Donnelly D
Neuroscience; 2007 May; 146(2):617-29. PubMed ID: 17363173
[TBL] [Abstract][Full Text] [Related]
58. CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity.
Hou ST; Jiang SX; Aylsworth A; Ferguson G; Slinn J; Hu H; Leung T; Kappler J; Kaibuchi K
J Neurochem; 2009 Nov; 111(3):870-81. PubMed ID: 19735446
[TBL] [Abstract][Full Text] [Related]
59. BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke.
Yu G; Wu F; Wang ES
Int J Clin Exp Pathol; 2015; 8(2):1213-25. PubMed ID: 25973006
[TBL] [Abstract][Full Text] [Related]
60. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
Meloni BP; Milani D; Edwards AB; Anderton RS; O'Hare Doig RL; Fitzgerald M; Palmer TN; Knuckey NW
Pharmacol Ther; 2015 Sep; 153():36-54. PubMed ID: 26048328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
